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Plasma Trimethylamine N-Oxide, a Gut
Microbe–Generated Phosphatidylcholine
Metabolite, Is Associated With
Atherosclerotic Burden
Vichai Senthong, MD, Xinmin S. Li, PHD, Timothy Hudec, BS, John Coughlin, BS, Yuping Wu, PHD, Bruce
Levison, PHD, Zeneng Wang, PHD, Stanley L. Hazen, MD, PHD, W.H. Wilson Tang, MD

T

he incidence of atherosclerotic coronary ar-

score II was recently developed, with a

ABBREVIATIONS

tery disease (CAD), a common cardiovascular

presumed improved prognostic value. It

AND ACRONYMS

disease (CVD), has been increasing and re-

consists of a combination of 2 anatomical

mains a leading cause of death around the world

(SYNTAX score and unprotected left main

(1,2). Despite the considerable attention to traditional

CAD) and 6 clinical variables (age, creatinine

risk factors (including age, sex, hypertension, dyslipi-

clearance, left ventricular ejection fraction,

demia, smoking, and diabetes) and use of modern

sex, chronic obstructive pulmonary disease,

pharmacotherapies, including high potency statin

and peripheral artery disease [PAD]). The

AUC = area under the receiveroperating curve

BMI = body mass index
CABG = coronary artery bypass
graft

CAD = coronary artery disease

therapy, at least a 50% residual risk remains (2–4).

SYNTAX score II has shown better long-term

Therefore, we are interested in identifying novel car-

(4-year) mortality prediction between coro-

diovascular risk factors to improve both our under-

nary artery bypass graft (CABG) surgery and

standing of the processes that contribute to CVD

percutaneous coronary intervention (PCI)

pathogenesis that have not been explained by tradi-

than the original SYNTAX score (20). Patients

tional or known risk factors, and the prevention and

with diffuse lesions present a higher risk for

treatment of CVD (5).

an adverse outcome after coronary revascu-

hs-cTnT = high-sensitivity

larization due to a higher incidence of reste-

cardiac troponin T

There is growing appreciation that gut microbes
participate in the overall metabolism of their host,

CI = conﬁdence interval
CVD = cardiovascular disease
eGFR = estimated glomerular
ﬁltration rate

hs-CRP = high-sensitivity
C-reactive protein

nosis, poor run-off in the target CABG, and an

MACE = major adverse cardiac

increased risk of adverse cardiovascular out-

events

comes (21–23).

NRI = net reclassiﬁcation index

and contribute to and are associated with car-

In this study, we aimed to examine the

diometabolic disease phenotypes in both animal

relationships between plasma TMAO levels

models of disease and in humans (6–9). In particular,

and coronary artery atherosclerotic lesion

disease

a role for gut microbes as participants in the devel-

complexity and burden quantiﬁed by SYN-

PCI = percutaneous coronary

opment of atherosclerosis and CVD has recently

TAX scores and lesion characteristics.

become acknowledged (10–12). Speciﬁcally, a gut microbial metabolite, trimethylamine N-oxide (TMAO),

OR = odds ratio
PAD = peripheral arterial

intervention

SYNTAX score = Synergy
Between Percutaneous

METHODS

Coronary Intervention with

has been shown to be atherogenic (12,13), and recent

Taxus and Cardiac Surgery

studies that examined microbial transplantation in

This is a single-center prospective cohort

score

recipients conﬁrmed a direct causal role for gut mi-

study approved by the Cleveland Clinic

TMAO = trimethylamine

crobes in transmitting atherosclerosis susceptibility

Institutional Review Board. All subjects pro-

N-oxide

and overall TMAO production (10). TMAO arises from

vided written informed consent.

gut microbiota metabolism following ingestion of di-

From the total of 989 patients who underwent

ets rich in phosphatidylcholine (or lecithin), the ma-

elective diagnostic cardiac catheterization at the

jor dietary source of choline, and carnitine, an

Cleveland Clinic between 2012 and 2014 who did

abundant nutrient in red meat (11,12,14,15). Moreover,

not have evidence of acute coronary syndrome

elevated TMAO levels have been shown to predict a

(cardiac troponin T level: <0.03 m g/l), we speciﬁcally

future risk of major adverse cardiac events (MACE),

excluded patients with a history of cardiac trans-

an increased prevalence of CVD, and have shown a

plantation, PCI, CABG, and who had undergone a

relationship with the number of diseased coronary

noncoronary artery procedure (structural heart pro-

vessels (11,12,14). However, a relationship between

cedure or for PAD), and patients who had no evidence

plasma TMAO levels and detailed characterization

of signiﬁcant CAD (total exclusion: 636 patients)

and quantiﬁcation of atherosclerosis burden has not

(Figure 1). Therefore, 353 consecutive patients with

been investigated.

evidence of signiﬁcant CAD, deﬁned by a diameter

The SYNTAX (Synergy Between Percutaneous
Coronary Intervention with Taxus and Cardiac Sur-

stenosis of $50% in vessels $1.5 mm, were included
in this study.

gery) trial produced the SYNTAX score, which is an

ANGIOGRAPHIC

angiographic

the

angiograms were obtained with Syngo Dynamics

scoring

system

to

determine

ANALYSIS. Images

of

coronary

complexity and burden of atherosclerotic CAD (16,17).

cardiovascular imaging software (Siemens Medical

The anatomical SYNTAX score has been shown to

Solutions USA, Inc., Malvern, Pennsylvania). The

predict MACE and long-term prognosis risks among

SYNTAX score was calculated for each patient using a

stable patients with CAD who have undergone coro-

computer program that consisted of sequential and

nary revascularization (18,19). However, due to some

interactive self-guided questions according to the

limitations of this score, including lack of clinical

SYNTAX score calculator version 2.11, and divided

variables and a purely anatomical focus, the SYNTAX

into tertiles according to the SYNTAX trial, which

F I G U R E 1 CONSORT (Consolidated Standards of Reporting Trials) Diagram

989 consenting patients who underwent elective
diagnostic cardiac catheterization at the Cleveland Clinic between
2012 and 2014

561 patients excluded because of prior
history of cardiac transplant (107),
prior CABG (137), prior PCI (79) and
non-coronary procedure (238)
(transcatheter valve implantation=30, PAD=208)

428 patients underwent angiographic analysis

75 patients excluded because no
evidence of significant CAD

Final: 353 patients included analyzed

289, 40, and 24 patients had low,
intermediate, and high anatomical
SYNTAX score, respectively

73, 193, and 87 patients had diffuse, focal,
and not met criteria for diffuse and focal
lesion, respectively

The ﬂow diagram showing the process used to deﬁne the study population is depicted. CABG
artery disease; PAD

peripheral artery disease; PCI

coronary artery bypass surgery; CAD

percutaneous coronary intervention; SYNTAX

coronary

Synergy Between Percutaneous Coronary

Intervention with Taxus and Cardiac Surgery.

were deﬁned as low (0 to 22), intermediate (23 to 32),

reduction in luminal diameter and a lesion length

and high ($33) SYNTAX scores. The SYNTAX score II

of <20.0 mm. We indicated diffuse lesions if at least 1

was calculated for each patient using a nomogram

diffuse lesion characteristic was present, focal lesions

and stratiﬁed according to tertiles of SYNTAX score II

if pure focal lesions were present, and nondiffuse and

for PCI as previously described (20,24). A diffuse

nonfocal lesions if they did not meet the criteria for

lesion was deﬁned as de novo CAD of >75% of the

those lesions. All angiograms were reviewed by an

length of any segment(s) proximal to the lesion, at the

interventional cardiologist who was blinded to TMAO

site of the lesion, or distal to the lesion that had a

level and clinical variable data.

vessel diameter of <2.0 mm; it was considered non-

LABORATORY TESTING. After informed consent was

diffuse if the arteries contained no such lesion (25).

obtained from all patients, fasting blood samples

A focal lesion was deﬁned as de novo CAD of >50%

were collected using ethylenediaminetetraacetic acid

tubes at the time of cardiac catheterization, which and SYNTAX score II (>21) and adjusted for the same
werethenimmediatelyprocessedandfrozenat 80C covariates from the regression model with traditional
untilanalysis.TMAOlevelsinplasmaweredetermined risk factors, lesion characteristic, hsCRP, eGFR,
using stable isotope dilution high-performance liquid BMI, and medications (27). All analyses were perchromatography
with
online
tandem
mass formed using JMP Pro version 10 (SAS Institute,
spectrometry on an API 5000 triple quadrupole mass Cary, North Carolina) and R (version 3.1.2, Vienna,
(AB
SCIEX,
Framing-ham, Austria). A p value <0.05 was considered statistically
Massachusetts), as previously described (12,26). The signiﬁcant.
assay shows inter- and intraday reproducibility (all
spectrometer

coefﬁcient of variations <7%) and accuracy (>98.5% RESULTS
across low, mid, and high values). Routine laboratory
tests and high-sensitivity C-reactive pro-tein (hsCRP) PATIENT CHARACTERISTICS. Baseline characteriswere measured using the Architect ci8200 platform tics of the 353 patients included in our study are
(Abbott Laboratories, Abbott Park, Illinois), and high- shown in Table 1. The mean age was 65 years of age,
sensitivity cardiac troponin T (hs-cTnT) was measured 79% were men, 80% had hypertension, and 30% had
by a high-sensitivity (ﬁfth generation) assay on a diabetes. The median TMAO was 5.48 m M (IQR: 3.41 to
Roche Cobas e411 platform (Roche Diagnostics, 9.76 m M), the median SYNTAX score was 11.0
Indianapolis, Indiana). Estimated glomerular ﬁltration (IQR: 4.0 to 18.5), and 289 (82%), 40 (11.3%), and 24
rate (eGFR) was esti-mated using the Modiﬁcation of (6.8%) patients had low, intermediate, and high
DietinRenalDiseaseequation.

SYNTAX scores, respectively. The baseline charac-

STATISTICAL ANALYSIS. Continuous data are pre- teristics according to SYNTAX score tertiles showed

sented as mean  SD or median (interquartile range that a patient with a higher SYNTAX score was more
[IQR])  and compared with the  Student  ttest likely to be older and have hypertension and diaor nonparametric test when appropriate. Categorical betes. In contrast, sex, a history of smoking, and
variables are presented as number (percent) and BMI were similar across SYNTAX score tertiles
compared between groups with chi-square tests. (Table 1). TMAO levels were signiﬁcantly higher with
Spearman correlation analysis was used to examine an increasing SYNTAX score, SYNTAX score II, and
the associations between TMAO and all clinical and hs-cTnT tertiles (Central Illustration).
laboratory variables. Comparisons among $3 groups CORRELATIONS WITH PLASMA TMAO LEVELS. Plasma
were evaluated by 1-way analysis of variance or the TMAO levels were strongly correlated with both
Kruskal-Wallis test according to whether or not the SYNTAX score and SYNTAX score II (Spearman’s
distribution was normal. Ordinal logistic regression correlation: r
0.61 and 0.62, respectively; both
analysis, adjusted for traditional Framingham risk p < 0.0001). Plasma TMAO was also correlated with
factors (including age, sex, hypertension, diabetes hs-cTnT, a measure of subclinical myonecrosis,
mellitus, smoking, low-density lipoprotein choles- because all hs-cTnT levels were below the diagnoterol, high-density lipoprotein cholesterol, and tri- stic cutoff for myocardial infarction (r
0.29;
glycerides), lesion characteristics, hsCRP, eGFR, body p < 0.0001). Following ordinal logistic regression
mass index (BMI), and medications (angiotensin- analysis adjusting for traditional risk factors
converting enzyme inhibitor/angiotensin receptor (including age, sex, hypertension, diabetes mellitus,
blocker, beta-blockers, statins, and aspirin) were used smoking,
low-density
lipoprotein
cholesterol,
to examine the association of TMAO with higher high-density lipoprotein cholesterol, and triglyceride)
SYNTAX score, SYNTAX score II, and hs-cTnT tertiles. and lesion characteristics, elevated TMAO levels
Univariate and multivariate logistic regression ana- remained independently associated with a higher
lyses were used to determine independent predictors tertile of the SYNTAX score (adjusted odds ratio [OR]:
of diffuse or focal lesions; the variables were en-tered 4.68; 95% conﬁdence interval [CI]: 2.35 to 9.29;
into the model, including the previously mentioned p < 0.0001), SYNTAX score II (adjusted OR: 2.02;
traditional risk factors and hs-cTnT (log-transformed). 95% CI: 1.72 to 3.01; p 0.0001), and hs-cTnT (adjusted
Category-free net reclassiﬁcation indexes (NRI) and OR: 1.34; 95% CI: 1.02 to 1.78; p
0.037). However,
areaunderthereceiver-operatingcharacteristiccurves when further adjusted for hsCRP, BMI, eGFR, and
(AUC) were calculated to eval-uate the incremental medications, the association between TMAO and
predictive ability of TMAO for predicting intermediate hs-cTnT was no longer signiﬁcant, whereas SYNTAX
orhighSYNTAXscore(>22)
score and SYNTAX score II remained signiﬁcant
(Table 2).

CENTRAL ILLUSTRATION Relationship Between TMAO and Measures of CAD Burden and Subclinical Myonecrosis

Senthong, V. et al. J Am Coll Cardiol. 2016;67(22):2620 8.

Trimethylamine N oxide (TMAO) has links to coronary artery disease (CAD) pathogenesis and is associated with adverse outcomes. One way to measure CAD complexity
and burden is via the SYNTAX score that came from the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial; the more
recent SYNTAX score II has been shown to have improved prognostic ability. In 353 stable patients with evidence of atherosclerotic CAD, concentrations of TMAO
were signiﬁcantly higher with (A) increasing SYNTAX score, (B) SYNTAX score II, and (C) subclinical myonecrosis (quantiﬁed by high sensitivity cardiac troponin
T [hs cTnT]) tertiles. PCI

percutaneous coronary intervention.

with stable CAD who underwent elective coronary

score II, and elevated hs-cTnT, even after adjust-

angiography (28), although renal insufﬁciency could

ments for traditional risk factors and lesion charac-

be a confounder. Furthermore, elevated TMAO

teristics on coronary artery angiography. A higher

levels were found to serve as an independent

plasma TMAO level was also shown to serve as an

predictor of higher SYNTAX score, higher SYNTAX

independent

predictor

for

the

presence

of

by showing striking and independent associations Furthermore, results from recent studies in mice fed a
between

TMAO

and

enhanced

coronary

artery high-fat diet also suggest that dietary TMAO may

atherosclerotic burden. Thus, the results are consis- exacerbate

impaired

glucose

tolerance,

obstruct

tent with the gut microbial TMAO pathway being hepatic insulin signaling, and promote adipose tissue
mechanistically linked with the development of CAD inﬂammation, which have been related to the
and the pathogenesis of CVD (12–14,35).
Previous

studies

showed

that

complexity and degree of atherosclerotic burden of
the

SYNTAX CAD (38). It is also of interest that recent studies have

score is a useful tool to risk stratify outcomes in further

implicated

ﬂavin

monooxygenase

3

in

stable patients with complex CAD (with or without atherosclerosis development in rodent models of
unprotected left main CAD) who have undergone diabetes (39).
revascularization by PCI or CABG. These studies STUDY LIMITATIONS. This was a single, tertiary
independently
predicted
MACE
and
all-cause referral center that recruited patients at the point of
mortality, which increased in the higher SYNTAX cardiac evaluation; therefore, we could not exclude
score tertiles (18,19). A high SYNTAX score is selection bias for patients who underwent diagnostic
also a marker of systemic atherosclerotic burden, cardiac catheterization (especially with relatively
which likely correlates with a poor prognosis (16,17).
preserved renal function). Because the patient
In our study, plasma TMAO levels were correlated population was a contemporary cohort (the last patient
with both the SYNTAX score (anatomical factors) and was enrolled in 2014), we did not have long-term
the SYNTAX score II (both anatomical and clinical outcome data. Despite all subjects being recruited at
factors). We also found elevated plasma TMAO to be an the time of coronary angiography while fasting for at
independent predictor for the presence of diffuse lesion least 10 h in anticipation of coronary angiography, we
characteristics, which represent markers of higher could not exclude the potential for dietary intake of
atherosclerotic burden and are associated with adverse choline or TMAO (e.g., large consumption of some ﬁsh
outcomes in CAD (22,36). In contrast,
elevated species) within 24 h before blood sampling. The relaplasma

TMAO levels showed an inverse and tively low number of the patients in the intermediate
independent association with the presence of focal and high SYNTAX score tertiles was a also limitation of
lesions, which indicates a lower atherosclerotic burden. our study. Furthermore, improvement in AUC for a
Importantly, despite the present study cohort including model is often very small in magnitude, yet the
stable subjects without evidence of acute coronary category-free NRI may tend to overstate the incresyndrome (cardiac troponin T level, <0.03 mg/l) at mental value of a biomarker.
presentation, elevated plasma TMAO was associated
with evidence of subclinical myonecrosis, as indicated CONCLUSIONS
by a higher level of hs-cTnT. It is thus conceivable that
subclinical myo-necrosis or high severity and an Fasting plasma TMAO level is an independent preatherosclerotic burden of CAD may occur in the setting dictor of high atherosclerotic burden in patients with
of elevated plasma TMAO levels. Taken together, our CAD. Higher TMAO levels can predict the presence of
current ﬁndings provided the additional support for a increased atherosclerotic burden and complexity, as
pro-atherogenic effect of elevated systemic levels of evidenced by higher SYNTAX scores and diffuse
TMAO. The mechanism of the relation between plasma lesion characteristics. Despite the associative nature
TMAO and atherosclerotic burden might be explained in this cross-sectional study, these ﬁndings are
by our previous studies that showed that higher plasma consistent with numerous previous mechanistic
TMAO was correlated with greater atherosclerotic demonstrations that have linked TMAO to the pathplaque size in both the arterial wall and aortic root in ogenesis of atherosclerosis, and the multiple reported
mice on diets supplemented with either TMAO or ﬁndings that have demonstrated associations becholine (12). TMAO may
have
direct
biological tween TMAO and cardiovascular risks. Further inactivity that facilitates the development or propagation vestigations into the mechanisms of elevated TMAO
of atherosclerosis plaque and suppres-sion of reverse leading to atherosclerotic burden and myonecrosis
cholesterol transport in in vivo mouse models (12,13). are warranted.
Moreover,

recent

studies

suggest

that

ﬂavin

monooxygenase 3, the major host enzyme responsible
for

forming

TMAO

trimethylamine,

is

from
a

gut

master

microbe–generated
regulator

cholesterol and sterol metabolism (37).

of

tissue

PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The in-

TRANSLATIONAL OUTLOOK: Further research is

testinal microbe-generated phosphatidylcholine metab-

needed to determine whether dietary or pharmacological

olite TMAO is related to the pathogenesis of

interventions that reduce plasma levels of TMAO can pre-

atherosclerotic CAD.

vent or retard the progression of coronary atherosclerosis.
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